Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study

IntroductionAnti-PD-1 immune checkpoint inhibitors have substantially changed melanoma management in both the adjuvant and advanced settings. This study aimed to estimate the percentage of stage III and IV melanoma patients exposed to different therapies and describe treatment patterns among anti-PD...

詳細記述

書誌詳細

主要な著者:	Miso Kim, Elizabeth M. Gaughan, Agueda Azpeitia, Aparna Rao, Maria L. Wei, Alexandra So, Xiaochen Zhong, Carola Berking, Ruixuan Jiang, Stéphane Dalle, Caroline Robert, Salma Alam, Tessa Davies, Dirk Debus, Marcin Dzienis, Sarah Danson, Ricky Frazer, Christoffer Gebhardt, Glenn Geidel, Jessica C. Hassel, Inga Hansen, Markus V. Heppt, Lina Hildebrandt, James Isaacs, Koung Jin Suh, Bhumsuk Keam, Yu Jung Kim, Thierry Lesimple, Phillipe Saiag, Ryan Weight, Alicia Delibes, Rosemarie Barnett, Clemens Krepler, Kavita Gandhi, Nawab Qizilbash, Irene Shui, Xiang-Lin Tan, Ryan J. Sullivan
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2026-07-01
シリーズ:	Frontiers in Immunology
主題:	adjuvant setting advanced anti-PD-1 melanoma real-world data treatment patterns
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1813387/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!